Replimune (REPL) Q2 2027 Earnings Call Transcript
TUDRIQEV launched with $450,000 price tag and early traction across oncology institutions.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.